Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO
NCT00180180 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2020-03-02
Summary
The purpose of this study is to describe the regional and global tumor hypoxia in head-and-neck cancer during percutaneous radiation therapy
Conditions
- Head and Neck Neoplasms
Sponsors & Collaborators
-
Technische Universität Dresden
lead OTHER
Principal Investigators
-
Joerg Kotzerke, MD · Department of Nuclear Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-07-31
- Primary Completion
- 2017-03-31
- Completion
- 2018-10-31
Countries
- Germany
Study Locations
More Related Trials
-
Assessment of Different Therapeutic Strategies in Patients With Head and Neck Neoplasms Treated With Radiotherapy
NCT06773039 ·Status: RECRUITING
-
Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer
NCT01617980 ·Status: TERMINATED ·Phase: NA
-
Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
NCT03989596 ·Status: UNKNOWN ·Phase: PHASE2
-
Prediction of Outcome After Chemoradiotherapy for Head and Neck Cancer Using Functional Imaging and Tumor Biology
NCT01829646 ·Status: RECRUITING ·Phase: NA
-
Hypofractionated Radiotherapy for HNSCC in Elderly Patients
NCT06768125 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?
NCT05217212 ·Status: RECRUITING
-
Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation
NCT02189967 ·Status: COMPLETED ·Phase: NA
-
Individualized Response-adaptive Radiation Dose Prescription in HNC Based on MRI
NCT05160714 ·Status: UNKNOWN ·Phase: PHASE1
-
Radiotherapy With Hyperthermia in Recurrent and Radiation-Induced Sarcomas
NCT04398095 ·Status: COMPLETED ·Phase: NA
-
Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT
NCT01212354 ·Status: UNKNOWN ·Phase: PHASE3
-
Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor
NCT00406289 ·Status: COMPLETED ·Phase: PHASE1
-
Radiotherapy of Head and Neck Cancer With SIB
NCT06831903 ·Status: RECRUITING
-
Multimodality- Adapted Dose Modification in Head and Neck Cancer Radiation Therapy 
NCT04933357 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
De-Intensification Radiotherapy Postoperative Head Neck
NCT02528955 ·Status: COMPLETED ·Phase: PHASE2
-
Emergency Radiotherapy in Metastatic Spinal Cord Compression of Patients With Non-small Cell Lung Cancer
NCT02000518 ·Status: COMPLETED
-
A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy
NCT00608751 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Optimising Radiation Therapy in Head and Neck Cancers Using Functional Image-Guided Radiotherapy and Novel Biomarkers
NCT04242459 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Radiotherapy Treatments for Neoplasms in the Head and Neck Region
NCT06335342 ·Status: RECRUITING
-
Functional Imaging in HNC Undergoing Chemoradiation
NCT00837980 ·Status: UNKNOWN
-
Upfront Neck Dissection Before Radiotherapy in Stage N3 Nasopharyngeal Carcinoma: A Retrospective Study
NCT07180173 ·Status: COMPLETED
-
Fractionated Radiosurgery for Painful Spinal Metastases
NCT01594892 ·Status: COMPLETED ·Phase: NA
-
High Dose Intensity Modulated Radiation Therapy in the Cervical Cancer With Metastatic Lymphadenopathies.
NCT01730651 ·Status: UNKNOWN ·Phase: NA
-
Characterization of Head and Neck Malignant Tumors Using an Electronic Nose
NCT01816919 ·Status: COMPLETED ·Phase: NA
-
The Use of Photobiomodulation in the Management of Radiodermatitis in Head and Neck Cancer Patients
NCT05557825 ·Status: COMPLETED
-
Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00771641 ·Status: COMPLETED ·Phase: PHASE3